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SUMMARY AT A GLANCE
Indigenous Australians are known to have
an increased risk of developing CKD. The
authors examined total renal volume (TRV)
in a cohort of Indigenous and non-
Indigenous preterm neonates, and found
that female Indigenous neonates had
significantly smaller TRV compared with
Indigenous male neonates.
ABSTRACT:
Aim: Indigenous Australians have an increased risk of developing chronic
kidney disease (CKD). Indigenous women have a higher rate of CKD than
men. In a cohort of Indigenous and non-Indigenous preterm neonates, we
assessed total renal volume (TRV) (a proxy indicator for nephron number).
We hypothesized that there would be no difference in renal volume
between these two groups at term corrected (37 weeks gestation).
Methods: Normally grown preterm neonates less than 32 weeks of gestation
were recruited and at term corrected dates, the neonates underwent renal
ultrasonography (TRV measurements), urine microalbumin-creatinine ratio
and serum analysis for Cystatin C measurement for estimated glomerular
filtration rate (eGFR) calculation.
Results: One hundred and five neonates (38 Indigenous; 67 non-Indige-
nous) were recruited. Indigenous neonates were significantly more prema-
ture and of lower birth weight. At term corrected age, Indigenous neonates
had a significantly smaller TRV (18.5 (4.2) vs 21.4 (5.1) cm3; P = 0.027)
despite no significant difference in body weight. Despite having a smaller
TRV, there was no significant difference in eGFR between Indigenous and
Non-indigenous neonates (47.8 [43.2–50.4] vs 46.2 [42.6–53.3] ml/min per
1.73 m2; P = 0.986). These infants achieve similar eGFR through hyperfiltra-
tion, which likely increases their future risk of CKD. There was no differ-
ence in microalbumin-creatinine ratio. Female Indigenous neonates,
however, had significantly smaller TRV compared with Indigenous male
neonates (15.9 (3.6) vs 20.6 (3.6) cm3; P = 0.006), despite no difference in
eGFR, birth weight, gestational age, and weight at term corrected.
Conclusion: The difference in TRV is likely to be an important risk factor
for the difference in morbidity and mortality from renal disease reported
between male and female Indigenous adults.
Australia’s Aboriginal and Torres Strait Islander people make
up approximately 2.8% of the Australian population.1 This
group, however, experiences a disproportionately higher
prevalence of morbidity and mortality compared with the
non-Indigenous Australian population. Aboriginal and
Torres Strait Islander women generally have more children
at a younger age compared with non-Indigenous women.
The mean birth weight of babies born to Indigenous
mothers is 3215 g, 140 g less than non-Indigenous neonates
and they are almost twice as likely to be of low birthweight
(less than 2500 g) or premature.2 The most recent estimates
indicate that an Indigenous male born between 2010 and
2012 can be expected to have a life expectancy of
69.1 years, approximately a decade less than a non-
Indigenous male (79.7 years). An Indigenous female born in
2010–2012 is expected to have a life expectancy of 74 years,
also approximately a decade less than a non-Indigenous
female.3 Data indicate that almost one in ten Aboriginal and
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Torres Strait Islander adults have diabetes mellitus, two in
three (65.3%) have at least one risk factor for cardiovascular
disease, and nearly one in five (17.9%) showed signs of
chronic kidney disease (CKD).4
Renal disease is a major health challenge for Aboriginal
and Torres Strait Islander people. In 2015, end-stage renal
disease and the need for renal replacement therapy was
nearly five times higher in Aboriginal and Torres Strait
Islander people.5 The major contributor to this dispropor-
tionately higher prevalence of renal disease is likely to be a
combination of modifiable risk factors, including foetal
growth restriction and low birth weight, prematurity, poor
nutrition in infancy, childhood and adult life, elevated body
mass index, diabetes mellitus, infections and inflammation.6
While, in non-Indigenous Australians, males experience an
excess of renal failure at a younger age, in the Indigenous
community it is females who experience renal failure more
commonly and often at a young age. This is important as
this places young Indigenous mothers at risk of renal
impairment which may have a profound effect on their foe-
tuses’ renal development and function.7
The human kidney develops from early gestation, with
the mesonephros and metanephros developing at about
5 weeks.8 The metanephros (which functions as the adult
kidney) continues to grow with an increasing number of
nephrons until 34–36 weeks of gestation when nephrogen-
esis is complete. Nephrogenesis starts in the juxtamedullary
region and then progresses in an outward direction.9 The
renin-angiotensin-aldosterone system and vascular endothe-
lial growth factor have crucial roles in nephrogenesis.10–12
While histopathological examination can determine neph-
ron number,13 this is not feasible for neonates. Renal vol-
ume measurements by ultrasonography have a good
correlation with nephron number14,15 and can be used as a
surrogate index of nephron number.
We carried out a study to compare renal volumes (and
hence nephron numbers NGlom) between a cohort of Indige-
nous and non-Indigenous premature neonates. We hypoth-
esized that there would be no difference in renal volumes
(and hence nephron) number between these two groups.
METHODS
Study population
This prospective study was carried out at the Department of
Neonatology, The Townsville Hospital, Queensland, Australia.
The study period was from August 2010 until October 2016,
and the region has approximately 10 000 births per year. Pre-
term neonates less than 32 weeks of gestation, with average
birth weights (weight between the 10th and 90th centile),
were eligible to participate in this study. Neonates with
growth restriction, or large for gestational age, or with con-
genital abnormalities were excluded. Once recruited, study
subjects were followed until discharge and assessment were
carried out at term corrected (37 weeks postmenstrual age
(PMA)). PMA for the preterm neonates was defined as fol-
lows: PMA = gestational age at birth (weeks) + postnatal age
in weeks.16 The Townsville Health District Human Research
Ethics Committee approved this study. Written consent was
obtained from parents of all participants.
Data collection
At term corrected, the neonates underwent renal ultraso-
nography, urine analysis for the microalbumin-creatinine
ratio (ACR) and venepuncture for cystatin C (CysC)
measurements.
Cystatin C measurement
We used CysC as it is a more reliable marker to assess renal
function in neonates.17,18 Serum CysC measurements were
carried out using an immunoturbidimetric assay designed
for use on the Beckman AU480 automated analyser plat-
form (Gentian, Australia). The assay range is 0.34–7.95 mg/
L, with an intra and inter-assay precision <10%. The Zappi-
telli CysC estimated glomerular filtration rate (eGFR) equa-
tion was used to calculate eGFR (GFR (mL/min per
1.73 m2) = 75.94/[serum CysC1.17]).19
Urine analysis for albumin
Urine ACR measurement was carried out on a randomly
collected specimen, using the Beckman Coulter microalbu-
min immunoturbidimetric assay on an automated Unicel
DxC analyser (Beckman Coulter, Australia). The assay was
calibrated using the SYNCHRON Systems MA calibrator spe-
cifically for urine assays (Beckman Australia), traceable to
the International Federation of Clinical Chemistry reference
range.
Renal ultrasonography
Renal ultrasonography was performed using the Philips
IU22 Ultrasound System (Philips Healthcare, Andover, MA,
USA) with a compact (small footprint) curved linear
5–8 MHz frequency transducer. The renal scans were carried
out by the same sonographer, with an intra-class coefficient
for the intra-observer variability of 0.85 (95%
CI = 0.73–0.91). In both kidneys, renal length (L), antero-
posterior diameter (AP), and transverse diameter (W) were
measured and renal volume (KV; cm3) was calculated using
the formula: KV = (π/6 × L × W × AP).20 The total renal
volume (TKV) (Right KV + Left KV) was also calculated.
Statistical analysis
The variables are expressed as means (standard deviation
(SD)) for continuous, normally distributed data and as
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median [Interquartile range [IQR]] for continuous, non-
normally distributed data. Students t-test or Mann–Whitney
U test was used where appropriate and a P value <0.05 was
considered statistically significant. D’Agostino-Pearson test21
was utilized to determine the normality of the variables and
statistical analyses were performed using MedCalc for Win-
dows, version 16.4.3 (MedCalc Software, Ostend, Belgium).
RESULTS
A total of 375 preterm neonates who fulfilled the inclusion
criteria were admitted during the study period, and there
were 33 deaths. One hundred eight of the available 345 neo-
nates were recruited, and a complete data set was available
for 105 neonates (38 Indigenous and 67 non-Indigenous).
The median birth weight was 908 [779–1158] g, and the
mean gestational age was 27.0 (2.1) weeks. There was an
almost equal number of male (N = 53) and female (N = 52)
neonates. There was no significant difference in the gesta-
tion (27.0 (2.4) vs 27.0 (1.8) weeks; P = 0.980) and birth
weight 920 [798–1320] vs 892 [770–1035] g; P = 0.062)
between male and female neonates. At term corrected gesta-
tion age, there were no significant differences in weight
(2566 (371) vs 2416 (382) g; P = 0.088) or TRV (21.4 (4.4)
vs 19.6 (5.5) cm3; P = 0.110) between male and female
neonates.
Indigenous neonates were more premature (26.1 (1.7) vs
27.5 (2.2) g; P = 0.001) and of lower birth weight
(830 [730–995] vs 970 [800–1274] g; P = 0.020). At term
corrected age, Indigenous preterm neonates had signifi-
cantly smaller TRV (18.5 (4.2) vs 21.4 (5.1) cm3; P = 0.027)
despite no significant differences in body weight (2476
(373) vs 2499 (389) g; P = 0.809) (Figs. 1 and 2, respec-
tively). Despite having smaller TRV at term corrected age,
there was no significant difference in eGFR between Indige-
nous and non-Indigenous preterm neonates (47.8
[43.2–50.4] vs 46.2 [42.6–53.3] ml/min per 1.73 m2;
P = 0.986) (Fig. 3). There was no difference in urine ACR
between Indigenous and non-Indigenous neonates (10.0
[6.2–28.8] vs 8.2 [5.0–17.0]; P = 0.312).
Female Indigenous preterm neonates had significantly
smaller TRV when compared with Indigenous male neo-
nates (15.9 (3.6) vs 20.6 (3.6) mL; P = 0.006, Fig. 4). There
was no significant difference in eGFR (51.6 [37.2–65.8] vs
44.8 [36.5–74.2]] mL/min per 1.73 m2; P = 0.307), birth
weight (890 (201) vs 913 (249) g; P = 0.771), gestational
age (26.7(1.6) vs 25.8(1.7) weeks; P = 0.110) or weight at
term corrected (2353 (389) vs 2573 (331) g; P = 0.150)
between Indigenous female and male neonates. There was
no significant difference in TRV between male and female
non-Indigenous neonates (22.0 (4.7) vs 20.8 (5.5) mL;
P = 0.404) (Fig. 4). Multiple linear regression model indi-
cated that TRV was positively correlated to weight at term
corrected but not gestation or birth weight (Table 1).
Fig. 1 At term corrected, Indigenous neonates had smaller renal volumes.
Fig. 2 No difference in body weight at term corrected. The vertical axis is
body weight (g).
Fig. 3 No difference in eGFR at term corrected (ml/min−1 per 1.73 m2).
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DISCUSSION
At term corrected gestational age, Indigenous preterm neo-
nates had significantly smaller renal volumes, and therefore
they had a lower NGlom on average than non-Indigenous
preterm neonates. Despite fewer NGlom, Indigenous neo-
nates had similar eGFR to non-Indigenous neonates. Total
eGFR is the product of the single-nephron GFR × NGlom.
22
Hence, Indigenous preterm neonates achieved similar eGFR
through single nephron hyperfiltration, a concept first pro-
posed by Brenner.23
Our data also found that female Indigenous neonates had
smaller renal volumes compared with Indigenous male pre-
term neonates, but there were no differences in birth
weight, gestational age, renal function and weight at term
corrected, between these two groups. Other investigators
have previously reported a difference in renal volume
between male and female Indigenous children. Spencer
et al.24 evaluated a cohort of 174 children aged between
5 and 18 years in an Aboriginal community with a high
prevalence of renal diseases in Northern Territory, Australia.
The investigators found that male Indigenous children had
larger renal volume adjusted to body surface area when
compared to female Indigenous children. Hoy et al.25 dem-
onstrated that Indigenous adults had 30% fewer glomeruli
(202 000 fewer glomeruli per kidney, or an estimated
404 000 fewer nephrons/individual, (P = 0.036),25,26 with a
mean glomerular volume that is 27% larger than that of the
non-Indigenous group (P = 0.016). Their data also showed
that female Indigenous persons had 5% fewer nephrons
when compared with male Indigenous persons.25
While Indigenous status is an important determinant of
CKD in the Australian population, gender is an important
determinant of the need for renal dialysis.27 In remote
Australia, the incidence of Indigenous women needing dial-
ysis is higher compared with Indigenous men.28 A retrospec-
tive cohort analysis, Australia and New Zealand Dialysis and
Transplant (ANZDATA) Registry from 2001 to 2013
(n = 21 832) reported that the incidence of dialysis in Indig-
enous women was higher than in Indigenous men (513 per
million population and 406 per million population, respec-
tively).27 The reverse was reported among non-Indigenous
people. Death associated with renal diseases between 1998
and 2012 was 3.9 times higher in Indigenous females and
2.6 times higher for Indigenous males when to compared
with non-Indigenous Australians.28 The causes of these dis-
parities need to be fully understood.
Reduced nephron endowment is likely to be an important
risk factor for CKD among Indigenous people. Compound-
ing factors during childhood and adolescence would further
set an Indigenous infant on a trajectory to develop CKD and
end-stage renal disease at a younger age compared with
their non-Indigenous Australian contemporaries. Hoy
et al.29 investigated the association between episodes of
acute post streptococcal glomerulonephritis (PSGN) and the
risk for CKD in later life in a cohort of 1519 residents of a
remote Australian Indigenous community, with high rates
of cardiovascular and renal disease. Approximately 13%
(200/1519) of the residents had at least one episode of
PSGN and, numerous episodes during childhood in
27 others. Elevated ACR level was noted with increasing
age. Group A streptococcal skin infections, often related to
scabies were identified in all PSGN episodes. For men and
women aged 10–39 years, approximately one in five had
PSGN. PSGN (5 years or more before assessment) showed a
significant correlation with ACR. A history of PSGN among
women aged 30–39 had a significant correlation with
reduced GFR. In both genders with a history of PSGN, the
adjusted odds ratios for an ACR to be above 34 g/mol (overt
albuminuria) was 4.6 (men) and 3.1 (women). The investi-
gators in this study concluded that PSGN contributes signifi-
cantly to the increased risk of CKD in that community.29
There are a few limitations to our data. Some of the neo-
nates were transferred back to hospitals nearer to their homes
before discharge from the hospital. Hence, less than a third of
the eligible patients were recruited into this study. The total
number of admissions during this study period was 375 neo-
nates, out of which 139 were Indigenous (139/375 = 37%).
In the final data set, data from 105 neonates were analyzed,
out of which 38 were indigenous (38/105 = 36%). Hence,
Fig. 4 Female Indigenous neonates have smaller renal volume (Mean (SD))
compared to Indigenous male neonates at term corrected, but this differ-
ence is not seen in the Non-Indigenous population. ( ) Female, ( ) male.
Table 1 Multiple linear regression analysis for total renal volume at term
corrected
Independent variables Coefficient P
Constant −2.066
Birth weight (g) 0.0012 0.707
Gestation (weeks) 0.360 0.344
Weight at term corrected 0.005 0.004
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while we were unable to eliminate bias, we believe that the
effect of selection bias in our data is minimal. We considered
all neonates from the Aboriginal and Torres Strait Islander
community as a single group and did not make any attempt to
divide this group further. We used TRV as a proxy indicator of
nephron number, and the use of CysC as a marker of renal
function in neonates is currently limited. We are currently fol-
lowing up these neonates until the age of 24 months.
In conclusion, Indigenous neonates are more premature
and smaller compared to non-Indigenous neonates. At term
corrected age, premature Indigenous neonates have smaller
renal volumes (hence nephron number) but similar eGFR.
Thus, they achieve similar eGFR through hyperfiltration,
which increases their risk of developing CKD over their life-
time. Female Indigenous neonates have smaller renal vol-
umes compared to Indigenous male neonates. We believe
this is an important reason for the difference in morbidity
and mortality from the renal disease between male and
female Indigenous adults.
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